Proteolysis has traditionally been considered as a radical way to terminate the function of a protein.
dramatically in recent years, as its role in human pathology has become increasingly clear. Autophagy plays an important role in development, and abnormal autophagy has been described in cancer, neurodegeneration, and other conditions. Galluzzi et al. [1] (see pp. 786-790) review the multiple roles of autophagy and discuss its intriguing connection with cell death. Although autophagy has been traditionally seen as a housekeeping process in charge of the turnover of aged or damaged organelles, the autophagocytic response to starvation or stress, by providing metabolic substrates, can be depicted also as a pro-survival mechanism. Thus the involvement of autophagy in the so-called type II, or autophagic, cell death, is somehow paradoxical. This article reviews the arguments for and against autophagy having a causal role in some types of cell death, covering a wide range of experimental models. The authors conclude that this evolutionarily conserved pro-survival response to stress might have acquired a role as supplier of metabolites in multicellular organisms, at the expense of individual cell deaths. Also, in tissues devoid of phagocytes, autophagy might take over the task of apoptotic body removal. In an accompanying review, Boya et al. [2] (see pp. 813-817) summarize recent findings underscoring the role of autophagy in cell corpse removal during development of the central nervous system. The authors discuss recent findings on the involvement of autophagy during embryonic development, with particular emphasis on the central nervous system, and development of the retina in particular. They review experimental evidence for autophagy driving the engulfment of dying cells during retinal neurogenesis, and they highlight autophagy as a means to provide the ATP needed for the correct removal of apoptotic cells in the developing retina.
Ubiquitin-and cell-membraneassociated degradation
Protein destruction is not the only mechanism that ubiquitin conjugation promotes to control protein activity. Ubiquitination of most plasma membrane proteins leads to their endocytosis and is also implicated in their sorting from the Golgi apparatus to the internal vesicles of MVBs (multivesicular bodies). Belgareh-Touzé et al. [3] (see pp. 791-796) describe several roles for the Rsp5 ubiquitin ligase in the regulation of intracellular trafficking in Saccharomyces cerevisiae, underlining the necessity to elucidate the mechanism allowing the specific recognition of substrates modified by this enzyme of the HECT family [4] . As with many other enzymes modifying various protein substrates, specific motifs, factors or adaptors might contribute to define the specific recognition of a target. Adaptor proteins might be required at every step, before and after the modification, regulating substrate access to modification, interactions and/or change to a different cell compartment. A good example of this type of process is the ERAD (endoplasmic-reticulum-associated degradation), a complex process that includes multiple steps: misfolded protein recognition, ubiquitination, dislocation to the cytosol, deglycosylation and proteasomal degradation. From the first step until cytosolic degradation, misfolded proteins have to cross the barrier of the endoplasmic reticulum membrane in a process named retrotranslocation. Different ERAD pathways have been reported, and they all converge in the Cdc48/p97/VCP (valosin-containing protein)-dependent retrotranslocation step. Ballar and Fang [5] describe in their review (see pp. 818-822) the regulation of ERAD via a new motif named VIM (p97/VCP-interacting motif). This is an original contribution of this team to identify and characterize the role of different elements involved in the recognition and regulation of the destiny of an ubiquitinated protein. The role of ubiquitin receptors in the ERAD pathways has been reviewed by Raasi and Wolf [6] .
Mechanisms of specificity regulating the UPS (ubiquitin-proteasome system)
Ubiquitin and UBLs (ubiquitin-like proteins) are now largely considered to be tagging molecules that are attached post-translationally to modulate the interaction affinity of the conjugated substrates for different partners. The UPS, in the broadest sense, determines the fate of most proteins and is therefore involved in the regulation of relevant cellular pathways, from the cell cycle to differentiation, and from survival to cell death. The complexity and specificity of the UPS depends not only on the accurate regulation of ubiquitin conjugation and deconjugation on substrates, but also on the deployment of many UBDs (ubiquitin-binding domains) with different recognition capabilities in the ubiquitininteracting proteins. UBDs come in different combinations of varieties and shapes and may display, and thus confer on the proteins in which they are embedded, exquisite specificity towards mono-and/or poly-ubiquitin chains, the lysine used for growth chain (ubiquitin has seven lysine residues available for isopeptide bonds), and the peptide attached [e.g. ubiquitin, SUMO (small ubiquitin-related modifier)].
Considering all this complexity, the characterization of the cellular ubiquitome has gathered increasing relevance as reviewed by Hjerpe and Rodríguez [7] (see pp. 823-827). These authors provide a succinct and useful technical overview on the approaches to analyse the pool of ubiquitinated proteins in different cell conditions, or on a smaller scale, to study the ubiquitinated state of a particular protein of interest (see also [8] ). From the overexpression of His 6 -tagged ubiquitin followed by Ni 2+ -chelate affinity chromatography, to the more recently developed affinity chromatography using a variety of UBDs that display distinct affinity for mono-or poly-ubiquitin and UBLs, coupled to MS, this emerging field will certainly yield useful insights into the involvement of the UPS in health and disease. One particular caveat of the identification of ubiquitinated proteins is the rapid deconjugation by cellular DUBs (deubiquitinating enzymes). Although initially thought to encode redundant enzymatic activities, DUBs, of which there are five subfamilies described, are now gathering the attention of basic researchers and pharmacological companies. The work of Goldenberg et al. [9] (see pp. 828-832), set in Progenra Inc., stresses that the UPS is altered in a wide range of pathologies including cancer, neurodegeneration and viral infections. UPS inhibition is a relevant target for therapeutic intervention [10] , yet the use of general proteasome inhibitors has been precluded by their high toxicity. Therefore the identification of specific DUB inhibitors is now a more feasible goal for novel treatments. The authors present a cost-efficient high-throughput assay for measuring DUB-proteolytic activity on ubiquitin-or UBL-fusion conjugates that allows the testing of thousands of inhibitory compounds to be selected for further pharmacological development and clinical trials. On a much smaller scale, commercial kits are also available to test for a particular DUB.
The regulation of ubiquitin and UBL conjugation to many substrates must be finely tuned to respond to particular cellular requirements, and the review by Marfany and Denuc [11] (see pp. 833-838) highlights that many E3 ligases as well as DUBs are recruited to multimeric platforms, which include regulatory activities together with structural scaffold and interacting proteins. This is of relevance in dynamic switchon/switch-off processes that integrate signalling pathways. They focus on some recent publications to illustrate several issues, among them the cross-talk between ubiquitin and UBL pathways (see also [12] ). One type of well-characterized multimeric platform is the SCF complex, the E3 ligases named after Skp1, cullin-1/Cdc53 and F-box proteins, the latter involved in substrate specificity. The review presented by Lannoo et al. [13] (see pp. 843-847) characterizes the C-terminal domains of plant F-box proteins as proteincarbohydrate interaction domains homologous with lectins. They stress that F-box proteins select substrates not only by protein-protein interactions, but also, importantly, by protein-sugar interactions [14] , thus bringing glycosylated substrates to the SCF complex for ubiquitination and subsequent proteasomal degradation. They finally conclude that plant and mammalian F-box proteins are functional analogues in nucleocytoplasmic glycoprotein degradation.
Regulation of transcription
The activity of some transcription factors is controlled by proteolysis via the UPS, UPS-independent proteolysis and post-translational modification by conjugation with ubiquitin or UBLs. Matentzoglu and Scheffner [15] (pp. 797-801) describe the role of the ubiquitin ligase E6-AP (E6-associated protein) in human disease, an E3 enzyme involved in p53 degradation. They highlight that E6-AP represents a clear example that inappropriate regulation of the proteins by the ubiquitin-conjugation system contributes to the development of human disease. Activation of E6-AP contributes to cervical carcinogenesis, whereas inactivation results in a neurodevelopmental disorder. E6-AP was originally isolated as a protein that binds to the E6 oncoprotein of HPVs (human papillomaviruses) associated with cervical cancer and, in complex with E6, targets the tumour suppressor p53 for ubiquitination and proteasomal degradation. Therefore infection with certain HPVs represents the most significant risk factor for the development of cervical cancer. However, loss of E6-AP activity is linked to the development of Angelman syndrome, a genetic neurological disorder. In spite of the knowledge acquired, the cellular pathways and processes controlled by E6-AP are still ill defined. In their review, the authors present three potentially powerful approaches to understand the consequences of the loss of E6-AP activity in mammalian cells.
Martínez-Lopez et al. [16] describes the role of SAM (S-adenosylmethionine) in cell proliferation (see pp. 848-852). SAM is the main methyl donor group in the cell, and is currently considered to be a key regulator of metabolism, proliferation, differentiation, apoptosis and cell death. Knockout models have been developed for the enzymes responsible for SAM synthesis and catabolism. These knockout mice develop steatosis and hepatocellular carcinoma, making them extremely useful to elucidate the molecular mechanisms underlying liver disease. Indeed, dramatic changes in the pattern of protein expression appear to determine liver disease progression. The NASH (non-alcoholic steatohepatitis) genomic fingerprint is due at least in part to changes in the activity of transcription factors typically regulated by ubiquitination, such as Sp1 (specificity protein 1), p53 and NF-κB (nuclear factor κB) [17] .
Piechaczyk and Farràs [18] (see pp. 864-867) describe the function and regulation of JunB, a member of the AP-1 (activator protein 1) transcription factor. This review shows another example for the notion that deregulation of protein stability plays an important role in cell proliferation. Recent data suggest a fine control of JunB protein stability during the cell cycle, with a prominent role for phosphorylationdependent proteasome-mediated degradation during the G 2 /M transition. Such reduction in JunB protein levels seems to be essential for proper mitosis. Gomard et al. [19] explore the degradation of other members of the AP-1 transcription factor, c-Fos and Fra-1 of the Fos family, in transformed and non-transformed cells (see pp. 858-863). Interestingly, like c-Fos, a bulk fraction of Fra-1 protein can be degraded by the proteasome without being ubiquitinated. Certain structural domains suggest that similar mechanisms may also apply to other members of the Fos family, such as Fra-2 and FosB. This reveals novel mechanisms for recognition and degradation of this protein family by the proteasome without requiring prior ubiquitination under particular cell signalling conditions.
Ubiquitin-like proteins
UBLs are now emerging as important regulators of protein function. In this session, mechanisms of protein function regulation by SUMO and NEDD8 (neural-precursor-cellexpressed developmentally down-regulated 8) and control of the SUMO conjugation pathway by different stresses were highlighted. Also, the emerging cross-talk between ubiquitin and UBLs was discussed.
Lang and Rodríguez [20] (see pp. 853-857) addressed the role of ubiquitin and UBLs in controlling the function of the NF-κB transcription factor. The NF-κB pathway is the integration point in many signalling events, which lead to the regulation of many processes, including inflammation and apoptosis. Therefore it is not surprising that the regulation of its activity is highly complex. The RelA (p65) member of the NF-κB family is the most abundant, and its natural inhibitor IκBα (inhibitor of NF-κB α) controls its activity. Ubiquitin, SUMO and NEDD8 pathways co-ordinate their actions for the fine and tight regulation of the stability of IκBα and ultimately in the control of the NF-κB pathway.
Upstream kinase complexes such as IKK (IκB kinase) phosphorylate IκBα, which leads to its recognition by the β-TrCP (β-transducin repeat-containing protein)-based SCF ubiquitin ligase, and targeting for proteasomal degradation. NEDDylation controls this process, as modification of cullins with NEDD8 enhances the activity of the ubiquitin ligase. SUMO conjugation of IκBα occurs in one of the lysine residues used by the ubiquitin pathway and, in this way, IκBα is protected from degradation. This highlights the complexity of the cross-talk between ubiquitin and UBLs to finely tune and control protein function and signal transduction.
Apart from the role of UBLs in controlling protein function, there are emerging data to suggest that the conjugation machineries are highly controlled. Tempé et al. [21] discuss the regulation of the SUMO pathway upon different stress stimuli such as DNA damage, hypoxia and oxidative stress (see pp. 874-878). In particular, H 2 O 2 has been used extensively as an oxidative stress and at low doses of H 2 O 2 (0.01-1 mM) SUMOylation is inhibited. This is a specific effect, as ubiquitin conjugation is not affected under these conditions. Mechanistically, H 2 O 2 causes a disulfide bridge between the cysteine residues of the SUMO E1 catalytic subunit (Uba2) and of the E2 conjugating enzyme (Ubc9). The authors suggest that high H 2 O 2 concentrations can also inhibit the function of SUMO isopeptidases and this can cause an overall increase in SUMO conjugation. As a well-established role for SUMO is transcriptional repression, these data suggest that H 2 O 2 cellular levels could act as a second messenger, and, by inhibiting SUMO conjugation, transcriptional repression could be reduced.
The conservation of the ubiquitin and UBL pathways in all eukaryotic systems make the use of lower and less complex genetic systems important for our understanding of the role of these pathways in complex biological processes. Talamillo et al. [22] study the role of SUMO pathway in Drosophila development (see pp. 868-873). They used a targeted inducible siRNA (small interfering RNA) approach for Smt3/SUMO in the prothoracic gland, which is responsible for the production of ecdysteroids. Reduction of SMT3 causes an increase in the cell size of the ring glands, but a reduction in the total cell number. These morphological changes are accompanied by a reduction in ecdysteroid production. They show further that the main defect is the reduction of cholesterol levels. The group is currently investigating changes in the transgenic animals of transcriptional programmes that are involved in these processes.
The role of the NEDD8 UBL in development and cell proliferation is well established. At the molecular level, the cullin family of proteins is the best-characterized substrate for NEDD8. However, new evidence suggests that the NEDD8 proteome may be more diverse than previously thought. With the use of proteomics, work from our group identified ribosomal proteins as novel substrates for NEDD8. In this case, the role of NEDD8 is to protect a subset of ribosomal proteins from destabilization. This was demonstrated by reducing NEDDylation in cells with the use of the NEDD8-specific protease NEDP1/SENP8/DEN1 or siRNA against the components of the NEDD8 E1 enzyme. However, under these de-NEDDylating conditions, the production of ribosomes is not compromised, suggesting that the effect of NEDD8 on ribosomal protein stability is not due to ribosome biogenesis stress. This also suggests that the levels of ribosomal proteins are not limiting for the production of ribosomes.
Regulation of proteasome activity
A well-known characteristic of the UPS is its capacity to modulate its action according to the cellular conditions and in response to multiple stimuli [23] . An important concept to take in account when analysing the function of this pathway is that, in addition to the target protein, enzymes and adaptors, the proteasome itself can change its activity. In addition to the 19S regulatory complex, PA28 (proteasome activator 28) can also interact with the core 20S complex, and promote the generation of antigenic peptides. Specific catalytic subunits named immunosubunits integrate the proteasome complex to increase its antigen-processing activity. Seifert and Krüger [24] have written an interesting paper about remodelling the UPS in response to interferons (see pp. 879-884). The importance of this process during the immune response to rapidly replicating viruses is obvious and is investigated intensively by many groups. The proteasome has been involved in so many different processes; the question addressed by Antón and Villasevil [25] is whether it exists an alternative to the proteasome for the degradation of cytosolic proteins (see pp. 839-842). They underline a possible alternative that considers the aminopeptidase tripeptidyl peptidase II, which has been suggested to perform some of the functions of the proteasome. The authors also discuss an alternative pathway which delivers cytosolic substrates to the lysosome for degradation. It would not be surprising to discover that proteolytic machineries are more intricate than originally suspected.
How many proteolytic or non-proteolytic alternatives should exist to co-ordinate all processes determining cellular homoeostasis? One would like to think that the drastic decision of targeting a protein for destruction will only be used when no other mechanism guarantees an appropriate response in due time and with the intensity required to confront a physiological or pathological situation. The high reversibility of many of the processes regulating protein destruction complicate our observations and interpretations. Technological improvements and new insights will determine our comprehension of such a complicated network of systems regulating protein destruction inside the eukaryotic cell.
